Spire Wealth Management Dyne Therapeutics, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$10.88 - $15.0 $4,352 - $6,000	400 New	400 $4,000
Q2 2022 Jul 22, 2022	SELL	$4.36 - $10.5 $1,744 - $4,200	-400 Reduced 50.0%	400 $3,000
Q3 2021 Oct 22, 2021	BUY	$15.6 - $21.46 $6,240 - $8,584	400 Added 100.0%	800 $13,000
Q2 2021 Jul 26, 2021	BUY	$15.94 - $22.33 $6,376 - $8,932	400 New	400 $8,000

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.23B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.